STOCKHOLDERS EQUITY (DEFICIT) (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 12, 2023 |
Oct. 26, 2023 |
Dec. 19, 2022 |
Dec. 16, 2022 |
Aug. 29, 2022 |
Jul. 28, 2022 |
Feb. 22, 2022 |
Nov. 29, 2019 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Jan. 01, 2023 |
|
Expenses for options and warrants granted to employees | $ 870,000 | $ 2,700,000 | |||||||||
Epenses for R & D obligation | 230,000 | 500,000 | |||||||||
Expenses was attributed to G & A | $ 640,000 | $ 2,200,000 | |||||||||
Common stock and treasury shares, Description | 1-for-6 basis and (ii) decrease the number of total authorized shares of common stock of the Company from 150,000,000 to 25,000,000 shares | ||||||||||
Common stock shares issuance | 437,692 | ||||||||||
Reverse stock split of common stock | As of the Effective Time, every 6 shares of issued and outstanding common stock were converted into one share of common stock | ||||||||||
Agents fee | $ 1,155,722 | $ 337,682 | |||||||||
Common stock, par value | $ 0.001 | $ 0.001 | |||||||||
Proceed from stock issuances | $ 485,000 | ||||||||||
Unpaid directors' fees | $ 172,670 | ||||||||||
Remining shares available for issuance | 91,559 | ||||||||||
Expected Dividends | 0.00% | 0.00% | |||||||||
Volatility range | 112.28% | ||||||||||
Common stock value | $ 2,383 | $ 1,570 | |||||||||
On July 5, 2023 | |||||||||||
Purchase price | $ 16.02 | ||||||||||
Agents fee | $ 365,000 | ||||||||||
Common stock, par value | $ 0.001 | ||||||||||
Exercise price | $ 0.0006 | ||||||||||
Pre-funded warrants | 78,021 | ||||||||||
Gross proceeds of stock | $ 4,000,000 | ||||||||||
Offering price | $ 16.0194 | ||||||||||
Proceed from stock issuances | $ 171,666 | ||||||||||
Common stock share issued, restricted | 78,021 | ||||||||||
Private Investors [Member] | |||||||||||
Common stock shares issuance | 563,016 | ||||||||||
Investor Private Placement Member | |||||||||||
Proceed from stock issuances | $ 640,000 | ||||||||||
2019 Incentive Plan [Member] | |||||||||||
Incentive plan, description | Equity Incentive Plan, the Company maintained a 2019 Omnibus Long-Term Incentive Plan (the “2019 Plan”). Following the approval by the shareholders of the 2021 Equity Incentive Plan, no additional awards have been or will be made under the 2019 Plan. As of December 31, 2023, 130,203 stock options had been issued under the 2019 Plan with terms between 5 years and 10 years, of which 60,414 remained outstanding | ||||||||||
Private Placement Securities [Member] | |||||||||||
Shares available for issuance, shares | 249,688 | ||||||||||
Exercise price | $ 16.80 | ||||||||||
Offering price | $ 16.80 | ||||||||||
Common stock share issued, restricted | 249,688 | ||||||||||
Securities Purchase Agreement [Member] | |||||||||||
Common stock shares issuance | 78,021 | ||||||||||
Received from common stock shares issued | $ 47 | ||||||||||
2021 Incentive Plan [Member] | |||||||||||
Stock options, issued | 232,101 | 166,666 | |||||||||
Black Scholes Pricing Model [Member] | |||||||||||
Grants shares | 10,878 | 23,240 | |||||||||
Grants shares, amount | $ 3,626 | $ 4,244 | |||||||||
Proceed from related party | $ 50,000 | $ 300,000 | $ 10,000 | $ 50,000 | |||||||
Average weighted remaining contructual life in years | 5 years 3 months 21 days | 5 years | 5 years | 5 years 3 months 21 days | |||||||
Expected Dividends | 0.00% | 0.00% | 0.00% | 0.00% | |||||||
Discount rates | 3.88% | 3.70% | 3.61% | 2.69% | |||||||
Volatility range | 112.25% | 116.47% | 116.42% | 120.99% | |||||||
Common stock value | $ 50,000 | $ 300,000 | $ 10,000 | $ 173,000 | $ 50,000 | ||||||
Black Scholes Pricing Model [Member] | 2021 [Member] | |||||||||||
Common stock purchased, related party | 31,836 | 28,831 | 28,747 | ||||||||
Average weighted remaining contructual life in years | 5 years | 5 years 9 months | 5 years 9 months | ||||||||
Expected Dividends | 0.00% | 0.00% | 0.00% | ||||||||
Discount rates | 3.60% | 3.25% | 1.88% | ||||||||
Volatility range | 116.41% | 121.19% | 130.18% |